The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 157 participants.

Also called NCT01966978

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 157 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01966978
Other papers using this trial's data
  • Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study BMJ open diabetes research & care, 2019 DOI, PubMed 31803482, PMC6887507 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01966978. Randomized; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2017-12 (actual). Results posted on 2019-10-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Acronym
SIMPLE
Condition
Diabetes Mellitus, Type 2
Condition
Diabetes
Intervention (Drug)
Metformin
Intervention (Drug)
Detemir
Intervention (Drug)
Liraglutide
Intervention (Drug)
Insulin Aspart
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct01966978
Content hash
a8fbac6b2cee064100e07ab3dace257645f19a39f3f8b315fc31d11e1921ba78